Chun-Ta Liao1,2, Chung-Jan Kang1,2, Li-Yu Lee2,3, Chuen Hsueh2,3, Chien-Yu Lin2,4, Kang-Hsing Fan2,4, Hung-Ming Wang2,5, Shu-Hang Ng2,6, Chih-Hung Lin2,7, Chung-Kan Tsao2,7, Tuan-Jen Fang1,2, Shiang-Fu Huang1,2, Kai-Ping Chang1,2, Ya-Lan Chang2,8, Lan Yan Yang2,9, Tzu-Chen Yen2,10. 1. Department of Otorhinolaryngology - Head and Neck Surgery, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 2. Department of Head and Neck Oncology Group, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 3. Department of Pathology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 4. Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 5. Department of Medical Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 6. Department of Diagnostic Radiology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 7. Department of Plastic and Reconstructive Surgery, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 8. Department of Nursing, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 9. Department of Biostatistics and Informatics Unit, Clinical Trial Center, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China. 10. Nuclear Medicine and Molecular Imaging Center, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, Republic of China.
Abstract
BACKGROUND: The purpose of this study was to investigate whether multidisciplinary team care (MDTC) is associated with outcomes in oral cavity squamous cell carcinoma (SCC). METHODS: We retrospectively examined 1616 patients with oral cavity SCC who underwent radical surgery between 1996 and 2011. The study participants were classified into 2 subgroups according to the use of MDTC. RESULTS: Five-year outcomes were significantly better in the MDTC group than in the no-MDTC group (neck control, 88% vs 84%, p = .0397; disease-specific survival [DSS], 83% vs 78%, p = .0114; and overall survival [OS], 70% vs 64%, p = .0002, respectively). Among patients who were scheduled to undergo adjuvant therapy, the number who completed their adjuvant treatment was significantly higher in the MDTC group than in the no-MDTC group (90% vs 60% to 70%, p < .001). CONCLUSION: The association of MDTC with improved outcomes may be potentially explained by a better therapeutic alliance between the patient and the tumor board, and/or a greater thoroughness in clinical management.
BACKGROUND: The purpose of this study was to investigate whether multidisciplinary team care (MDTC) is associated with outcomes in oral cavity squamous cell carcinoma (SCC). METHODS: We retrospectively examined 1616 patients with oral cavity SCC who underwent radical surgery between 1996 and 2011. The study participants were classified into 2 subgroups according to the use of MDTC. RESULTS: Five-year outcomes were significantly better in the MDTC group than in the no-MDTC group (neck control, 88% vs 84%, p = .0397; disease-specific survival [DSS], 83% vs 78%, p = .0114; and overall survival [OS], 70% vs 64%, p = .0002, respectively). Among patients who were scheduled to undergo adjuvant therapy, the number who completed their adjuvant treatment was significantly higher in the MDTC group than in the no-MDTC group (90% vs 60% to 70%, p < .001). CONCLUSION: The association of MDTC with improved outcomes may be potentially explained by a better therapeutic alliance between the patient and the tumor board, and/or a greater thoroughness in clinical management.
Authors: Allen S Ho; Sungjin Kim; Mourad Tighiouart; Alain Mita; Kevin S Scher; Joel B Epstein; Anna Laury; Ravi Prasad; Nabilah Ali; Chrysanta Patio; Jon Mallen-St Clair; Zachary S Zumsteg Journal: Cancer Date: 2018-05-09 Impact factor: 6.860
Authors: Marius Freytag; Ulrich Herrlinger; Stefan Hauser; Franz G Bauernfeind; Maria A Gonzalez-Carmona; Jennifer Landsberg; Jens Buermann; Hartmut Vatter; Tobias Holderried; Thorsten Send; Martin Schumacher; Arne Koscielny; Georg Feldmann; Mario Heine; Dirk Skowasch; Niklas Schäfer; Benjamin Funke; Michael Neumann; Ingo G H Schmidt-Wolf Journal: BMC Cancer Date: 2020-04-28 Impact factor: 4.430
Authors: Harish Dharmarajan; Jennifer L Anderson; Seungwon Kim; Shaum Sridharan; Umamaheswar Duvvuri; Robert L Ferris; Mario G Solari; David A Clump; Heath D Skinner; James P Ohr; Dan P Zandberg; Barton Branstetter; Marion A Hughes; Katie S Traylor; Raja Seethala; Simion I Chiosea; Marci L Nilsen; Jonas T Johnson; Mark W Kubik Journal: Head Neck Date: 2020-04-27 Impact factor: 3.147